Ligand validation:5XI5

PN6: (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione

PN6 is a Ligand Of Interest in 5XI5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XI5_PN6_B_506	65%	17%	0.159	0.96	1.81	1.84	5	8	2	0	100%	1
5XI5_PN6_D_503	22%	16%	0.252	0.866	1.87	1.83	7	8	1	0	100%	1
6S8K_PN6_B_501	47%	9%	0.154	0.891	2.21	2.25	10	10	3	0	100%	1
5C8Y_PN6_B_504	39%	12%	0.246	0.953	1.97	2.15	6	9	0	0	100%	1
6S8L_PN6_B_501	23%	9%	0.219	0.839	2.17	2.27	10	9	4	0	100%	0.75

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.